The Lancet Child & Adolescent Health in conversation with

Kyeng Mercy and Nuria Sanchez Clemente on mpox in children in Africa


Listen Later

Mpox continues to spread in Africa and young children are experiencing the highest mpox burden and mortality of all ages. 

In this episode Kyeng Mercy, epidemiologist at Africa Centres for Disease Control and Prevention takes us through the continental response to mpox, the Africa CDC data on mpox in children younger than 15 years, and African priorities in response to the mpox public health emergency. 

Alongside her, Nuria Clemente Sanchez, paediatric infectious disease specialist at City St George's, University of London shares what paediatricians and clinicians need to know about how mpox presents and the latest information on mpox vaccine and therapeutic trials.

Mpox among children in Africa https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(25)00064-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanchi

Hidden in plain sight: the threat of mpox to children and adolescents https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(24)00298-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanchi

Paediatric, maternal, and congenital mpox: a systematic review and meta-analysis https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(23)00607-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanchi

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://www.linkedin.com/company/lanchi/
https://youtube.com/thelancettv

...more
View all episodesView all episodes
Download on the App Store

The Lancet Child & Adolescent Health in conversation withBy The Lancet Group


More shows like The Lancet Child & Adolescent Health in conversation with

View all
The Lancet Voice by The Lancet Group

The Lancet Voice

23 Listeners

The Lancet Digital Health in conversation with by The Lancet Group

The Lancet Digital Health in conversation with

0 Listeners

The Lancet Global Health in conversation with by The Lancet Group

The Lancet Global Health in conversation with

2 Listeners

The Lancet Oncology in conversation with by The Lancet Group

The Lancet Oncology in conversation with

1 Listeners

The Lancet Psychiatry in conversation with by The Lancet Group

The Lancet Psychiatry in conversation with

0 Listeners

The Lancet Respiratory Medicine in conversation with by The Lancet Group

The Lancet Respiratory Medicine in conversation with

1 Listeners

The Lancet in conversation with by The Lancet Group

The Lancet in conversation with

0 Listeners

The Lancet Haematology in conversation with by The Lancet Group

The Lancet Haematology in conversation with

0 Listeners

The Lancet Gastroenterology & Hepatology in conversation with by The Lancet Group

The Lancet Gastroenterology & Hepatology in conversation with

0 Listeners

The Lancet Diabetes & Endocrinology in conversation with by The Lancet Group

The Lancet Diabetes & Endocrinology in conversation with

1 Listeners

The Lancet Infectious Diseases in conversation with by The Lancet Group

The Lancet Infectious Diseases in conversation with

0 Listeners

The Lancet Healthy Longevity in conversation with by The Lancet Group

The Lancet Healthy Longevity in conversation with

0 Listeners

The Lancet Public Health in conversation with by The Lancet Group

The Lancet Public Health in conversation with

1 Listeners

The Lancet Microbe in conversation with by The Lancet Group

The Lancet Microbe in conversation with

0 Listeners

In conversation with... by The Lancet Neurology

In conversation with...

0 Listeners

eBioMedicine in conversation with by The Lancet Group

eBioMedicine in conversation with

0 Listeners

eClinicalMedicine in conversation with by The Lancet Group

eClinicalMedicine in conversation with

0 Listeners

The Lancet Rheumatology in conversation with by The Lancet Group

The Lancet Rheumatology in conversation with

0 Listeners

The Lancet Regional Health in conversation with by The Lancet Group

The Lancet Regional Health in conversation with

0 Listeners